Target intelligence / Profile preview

Protein kinase N2 (PKN2)

Target
PKN2
Molecular classification
Enzyme, Kinase, Serine/threonine-protein kinase, AGC kinase family, Rho/Rac effector, Protein kinase N (PKN) family
01

Overview

Protein kinase N2 (PKN2) is a serine/threonine-protein kinase and a member of the protein kinase N (PKN) family, encoded by the PKN2 gene. It acts as a downstream effector for Rho/Rac GTPases, regulating processes such as cell cycle progression, actin cytoskeleton organization, cell adhesion, migration, and transcriptional activation. PKN2 is essential for proper cell division and differentiation, participates in signaling pathways controlling apoptosis and cell motility, and plays a pivotal role in glucose and lipid metabolism, particularly by modulating insulin responsiveness in skeletal muscle. It has been implicated in cancer cell invasion and migration, certain developmental syndromes, and viral infections such as hepatitis C virus, and is considered a relevant therapeutic target for diverse biological and pathological processes.

Other names
PRK2PRKCL2PKN gammaProtein kinase C-like 2Protein-kinase C-related kinase 2Protease-activated kinase 2STK7Cardiolipin-activated protein kinase Pak2PRO2042
02

Mechanism of action

Most small-molecule inhibitors act as ATP-competitive kinase inhibitors, inhibiting the kinase activity of PKN2, thereby modulating downstream cell signaling. Inhibitors of PKN2 affect processes such as tumor invasion and cell migration via interference with phosphorylation events.

03

Biological functions

Cell cycle progression regulationPositive regulation of mitotic cell cycleActin cytoskeleton assemblyCell migrationCell adhesionTumor cell invasionTranscription activationProtein phosphorylationRegulation of glucose and lipid metabolismSignal transductionRegulation of cytokinesisApoptotic process
04

Disease associations

Cancer (tumor cell invasion, migration, adhesion)Metabolic disorders (regulation of insulin signaling, impact in type 2 diabetes, glucose and lipid homeostasis)Developmental disorders (associated with syndromes such as toe syndactyly, telecanthus, anogenital and renal malformations)Infection (direct role in viral genome replication; interaction with hepatitis C virus (HCV))Other (general roles due to broad impact on cell signaling and apoptosis)
05

Safety considerations

Embryonic lethality in knockout mice indicates PKN2 is essential for development, suggesting potential safety challenges if targeted systemicallyBroad physiological roles mean inhibition may affect normal cell cycle and cytoskeletal dynamics, raising concerns for off-target effects and toxicity
06

Interacting drugs

Multiple kinase inhibitors (specific small-molecule inhibitors of serine/threonine kinases are active at PKN2, but no uniquely PKN2-selective, clinically approved agent as of the search; PKN2 is included in kinase inhibitor screens such as DiscoveRx KINOMEscan and EMD Millipore KinaseProfiler)

2 more in the full profile.

07

Biomarkers

PKN2 expression/activity may serve as a biomarker for:Cell cycle regulation statusTumor cell invasivenessInsulin responsiveness in skeletal muscle (explored in type 2 diabetes research)

Beyond the preview

Go deeper on Protein kinase N2 (PKN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase N2 (PKN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call